STUDIES ON A SUBSTANCE THAT PROMOTES TUMOR HOMOGRAFT SURVIVAL (THE "ENHANCING SUBSTANCE") : ITS DISTRIBUTION AND SOME PROPERTIES by Kandutsch, A. A. & Reinert-Wenck, U.
STUDIES  ON  A  SUBSTANCE  THAT  PROMOTES  TUMOR 
HOMOGRAFT  SURVIVAL  (THE  "ENHANCING 
SUBSTANCE") 
ITS DISTRIBUTION AND SO~E  PROPERTIES*' 
BY A. A. KANDUTSCH, PH.D., AND U. REINERT-WENCK,§ Sc.D. 
(From the Roscoe B. Jackson Memorial Laboratory, Bar Harbor) 
(Received for publication,  October 10, 1956) 
Like homografts of normal tissues, tumors grafted between unrelated strains 
of mice may survive for a short period of time but are, in most cases, ultimately 
rejected. However, it is now well established that in certain tumor-host com- 
binations,  tumor homografts  can  be induced  to  survive and  grow until  the 
death  of the mouse,  by pretreating  the host  with killed  tissue  preparations 
(see references 2 and 3 for extensive bibliography). This phenomenon has been 
called  the  "enhancing effect." Possibly similar  are  the  accelerant effects of 
certain tumor preparations on tumor isografts (4-7), and the prolongation of 
the life of normal skin homografts in pretreated mice (8). The observation that 
the  *t-globulin fraction from rabbits  or mice  immunized  with  killed  tissues 
from the donor strain can also induce homograft survival (9), indicates that 
the mechanism has an immunologic basis and that the active substance is an 
isoantigen. The possible modes of action by which antibody to donor tissues 
may increase the survival of homografts has been discussed in recent publica- 
tions (8, 10). 
The enhancing  factor has been demonstrated in  tumor, spleen, kidney, and liver 
(11), but not in muscle,  brain, or in lyophilized  whole blood  (12). Its presence  in 
untreated whole blood has been demonstrated (13). However somewhat  special test 
conditions  were needed.  Fractionation studies  have shown enhancing  activity to be 
present in mitochondrial  and microsomal preparations (14), and in high speed super- 
nate fractions (15). Accelerant  activity has been found in mitochondrial  and micro- 
somal preparations (5), in a nudeoprotein prepared from the isolated nuclei of ascites 
tumor ceils (6), and in an acetone-soluble  tumor fraction (7). With the exception of 
the acetone-soluble  factor, in all cases in which  these factors were investigated the 
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active factors were non-dialyzable, labile to heat, and to extreme alkaline or acid pH, 
and resistant to the action of enzymes. 
The  present  study  deals  with  quantitative  measurements  of  enhancing 
activity in organs and in certain fractions prepared from tumor tissue and with 
some chemical properties of the active substance. 
Materials  and Methods 
The Assay.--Sarcoma I, which arose in strain  A  mice and which was carried  in this  line 
was used as the homograft (3).  Mice of strain  BI0.D2 (a C57BL/10  subline), 7 to 12 weeks 
old when treatment was begun, were used as hosts.  Tissues to be fractionated or tested for 
activity  were obtained from strain  A  mice, washed in saline,  and stored in a deep-freeze at 
--15°C. until  used. Before injection,  all  tissues  or tissue  fractions  were lyophilized,  ground in 
a mortar, and suspended in saline  by homogenizing in  a glass  homogenizer. Dosage was based 
on Kjeldahl nitrogen and the total dose was distributed over 3 intrapcritoneal  injections  4 
days apart. Two to four dose levels  were given and I0 mice (5 female, 5 male) were used at 
each level.  Approximately I0  days after  the  last  injection,  live  bits  of  tumor were transplanted 
subcutaneously into the dorsal region of the host mice with a trocar.  A positive  test  for the 
active substance was indicated by the progressive  growth of  the tumor until  the death of the 
mouse. 
Although the tumor was transplanted into an untreated group of host mice in each ex- 
periment, these control groups are not included in the following  tables  since  the tumor grew 
in only two untreated mice out of the several  hundred used in all  experiments. 
Chemica/Dete~*mi~s.--Nitrogen  was determined by a semi-micro  Kjeldahl method. 
Nucleic acids were extracted by the procedure described by Ceriotti  (16).  DNA  was deter- 
mined by the method of Dische (17) corrected for interference  as described by Dische (18). 
RNA  was determined by the orcinol  method as described by Ceriotti (16).  Hexosamine was 
determined by the Elson-Morgan method as modified by Boas (19). 
EXPERIMENTAL 
The Bioassay.-- 
The response to the injection of graded doses of killed tissue was influenced to a 
considerable extent by changes in the growth characteristics of the tumor used as the 
graft. Hence, the apparent activity of a single tumor preparation varied considerably 
from experiment to experiment and it was necessary that a wide dose range be covered 
to insure at least one level in the sensitive range. With this procedure and with the 
small numbers of mice that it was practical to use at each dose level, a graded response 
to dose was not always evident. Since this was true, the results obtained with the 
different dose levels were, in most cases, combined and are presented in the tables as a 
single value. That the response to dose is quantitative when large numbers of animals 
are used is shown by Fig. 1 in which 14 individual dose-response curves obtained with 
similar tumor preparations in 10 different experiments are averaged. It is also apparent 
from Fig. 1 that the tumor homograft can be induced to survive by relatively small 
doses of killed tissue and grow until it kills the mouse, 50 per cent deaths being ob- 
tained with a dose of approximately 0.15 rag. N or approximately 1.5 rag. dry weight 
of lyophilized tumor in an average experiment. Neither sex nor age appeared to be 
important variables in  the  bioassay. However,  the  response  to  a  preparation was A.  A.  KANDUTSCH  AND  U.  REINERT-WENCK  127 
much reduced when the tumor was transplanted as a cell suspension rather than by 
trocar as described above. 
Distribution in Organs and Tissues.--Tumor, liver, spleen, and kidneys from 
A  strain mice were collected, washed,  and homogenized.  Stomachs were re- 
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Fzo. 1. Dose response  curve. Points on the curve were obtained by averaging 14 individual 
dose response  curves when 10 mice were used for each point. Only 5 of the 14 curves extended 
to 1.5 nag. N/mouse. Vertical lines represent the standard error of the mean. 
moved, washed, and the glandular mucosal lining was scraped from the pyloric 
region with a spatula. All preparations were freeze-dried and nitrogen analyses 
were made on the dried materials. Stomach mucosa was of interest because of 
the high concentrations of blood group substances in such preparations from 
other animals and analyses on the lyophilized mucosa preparation from mouse 
stomach showed the presence of 1.2 per cent hexosamine as compared to 0.55 128  SUBSTANCE  PROMOTING  TUMOR  HOHOGRAFT  SURVIVAL 
per cent for the part of the stomach remaining after the glandular mucosa had 
been removed. In agreement with Kaliss and Snell (11),  tumor and spleen were 
of approximately equal activity while kidney,  liver, and  the stomach prepara- 
tions possessed  relatively small amounts  of activity (Table I). 
Activities of Tumor Fractions.--In  a  typical fractionation,  tumor  tissue  was 
divided into 4  different fractions by the following procedures:-- 
Approximately 260 gin. wet weight of Sarcoma I  was homogenized in a  Waring blendor 
with 200 ml. of 0.14 m saline. To the homogenate were added 450 ml. of saline and the sus- 
pension was centrifuged in a  refrigerated centrifuge at 3°C. for 30 minutes at 4500  g. The 
supemate was separated, and a  portion was adjusted to pH 5.4 with 0.1 N HCI, allowed to 
stand 15 minutes in the refrigerator then centrifuged at 4500 g for 30 minutes. The resulting 
supernate was lyophilized (froztion 1) and the fraction precipitated by the acid was washed 
with 0.14 It saline at pH 5.4 (frazt/on 2). This fraction contained most of the ribonudeoprotein 
(RNAP) of the tissue; in terms of lipide-free dry weight, 17 per cent of this fraction was RNA. 
TABLE I 
Distribution of Enhancing Activity in Organs and Tissues 
Tissue  Per cent of mice dying 
out of 30* 
Tumor (sarcoma I) 
Spleen 
Kidney 
Liver 
Stomach glandular mucosa 
Stomach after removing glandular mucosa 
47 
40 
00 
3.3 
3.3 
13.3 
* Total dose levels of 1.0, 0.3, and 0.05 nag ~ per mouse were administered to groups of 10 
mice. 
The sediment obtained  by centrifuging the initial homogenate was homogenized with 0.14 
v  saline and centrifuged at 2000 g. This step was repeated three times, the supernate being 
discarded  each time.  The resulting product  is referred to in following experiments as low 
speed sediment (LSS). A desoxyribonucleoprotein (DNAP) fraction (fraction 3) was prepared 
from the LSS by extracting with 1 ~  NaC1 essentially as described by Mirsky and Pollister 
(20). The nudeoprotein was purified by precipitating it four times from 0.14 M saline. In some 
experiments, the DNAP fraction was extracted with distilled water rather than with  1 
NaCl. DNAP fractions formed highly viscous solutions in distilled water or 1 M NaCl and 
from 27 to 37 per cent of the lipide-free dry weight was DNA. The material remaining after 
extraction with molar NaC1 was washed two more times with molar NaC1 and three times with 
distilled water to give fracti~m 4.  All fractions were freeze-dried and stored in a  deep-freeze 
until used. Nitrogen was determined on the lyophilized materials and nitrogen, DNA, RNA, 
and  hexosamine were determined  after extracting weighed mounts  of the fractions  in  a 
Soxhlet apparatus for 4 hours with alcohol and 4 hours with ether and drying in a desiccator. 
Lipide was estimated by evaporating an aliquot of the extracts at 110°C. and weighing. The 
presence of hexosamine was considered to indicate the presence of a  mucopolysacchatide or 
mucoprotein. However, it is probable that at least some of the hexesamine contained in the 
supernate at pH 5.4 was a  component of smaller molecules.  Hexosamine, lipide, and  RNA 
were present to some extent in all fractions (Table II). A.  A.  KANDUTSCH AND U.  REINERT-WENCK  129 
The supernate at pH 5.4 (fraction 1, Table II) appeared to be less active than 
the other fractions while the insoluble  residue  fraction  (fraction 4,  Table  II) 
appeared to be the most active. The presence of high levels of activity in the 
fraction precipitated  at pH 5.4 and in the DNAP fraction was in agreement 
with  earlier  reports  that  microsomal fractions and  a  nucleoprotein  prepared 
from isolated nuclei possessed accelerant or enhancing activity. However, the 
active factor did not appear  to be  a  desoxyribonucleoprotein  since fractions 
which possessed no detectable DNA (fraction  1)  or only trace amounts  (frac- 
tion 2)  possessed considerable  activity.  On  the other  hand,  even  the  purest 
DNAP  obtained  was  contaminated  by  a  detectable  amount  of  hexosamine 
(fraction 3 a). Neither was there any apparent relationship between RNA con- 
TABLE II 
Analysis and A cgvity of Tumor Fravgons 
Fraction 
No. 
1° 
2. 
3. 
3a.§ 
4. 
Description 
Supernate pH 5.4 
Ppt. pH 5.4 (RNAP) 
Sol. 1 ~r NaC1 (DNAP) 
¢¢ 
Low speed sediment in- 
soluble  1  ~  NaC1 
(residue) 
* Kjeldahi nitrogen determined 
Mg.  DNA 
Mg.  N* 
0.0 
0.013 
1.89 
2.76 
0.143 
Mg. RNA 
Mg. N* 
0.204 
1.023 
0.297 
0.060 
0.102 
on lipide-free fractions. 
Mg. hexosamine  MS. lipide 
Mg. N*  Mg. N * 
0.047  2.10 
0.022  3.44 
0.018  10.45 
0.007  2.33 
0.034  2.11 
Per cent 
Mice dyi 
out of 3q 
57 
67 
70 
83 
Total dose levels of 1.0, 0.3, and 0.05 rag. s/mouse were administered  to groups of 10 
mice. 
§ This relativdy pure DNAP fraction was prepared and tested  in an earlier experiment. 
At levels of 2.0 and 0.75 rag. s  per mouse it resulted in the death of 10 and 8 out of 10 mice 
respectively. 
centration and  activity,  residue  and  DNAP fractions being fuUy as active as 
the RNA-rich fraction precipitated at pH 5.4. 
In further studies on the ribonudeoprotcin  fraction the acid precipitate  obtained  by ad- 
justing  the pH to 5.4 was resuspended in and reprecipitated  twice from a 0.5 M NaHCOs 
solution according to a procedure for purifying a ribonucleoprotein  (20). The material  in- 
soluble in 0.5 g NaHCO3 was discarded each time. The reprecipitated  fraction was di~yzed 
overnight against distilled water and lyophilized. After this treatment the fraction no longer 
possessed enhancing activity. To determine at which step activity was lost from the acid- 
precipitated  materials,  portions  of an active pH 5.4 precipitate  were resuspended in saline 
and adjusted to pH 7.2 with NaHCOa or in 0.5 xf NaHCOa (final pH 8.0). After centrifuging 
these suspensions for 30 minutes at 4500 g, the sediment was separated  and the material in 
the supernate was again precipitated by adjusting the pH to 5.4. Both fractions were lyophil- 
ized. 
As shown in Table III, the activity appeared to be mainly associated with the 
materials that were centrifuged from the alkaline suspension. In these fractions 130  SUBSTANCE PROMOTING TUMOR HOMOGRAFr  SURVIVAL 
the concentration of RNA was reduced while the concentration of hexosamine 
appeared to be somewhat increased. 
The fact that materials sedimented at  low centrifugal speeds,  such as the 
LSS and the insoluble residue fraction (fraction 4)  were highly active, made 
them particularly useful for studies on the stability characteristics of the en- 
hancing substance, since added reagents could be removed by sedimenfing the 
tumor fraction in a centrifuge. 
Extraction  with  Organic Solvents.--It  has been suggested  that  the antigens 
involved in transplantation may be lipides (21) likewise, the preparation of an 
acetone-soluble accelerant fraction from a  mouse mammary tumor has been 
reported (7). On the other hand, after extraction with alcohol, ether, or dioxane 
for short periods of time (14) or with cold acetone (15),  tumor preparations 
were still capable of promoting homograft survival. However, all lipides may 
TABLE III 
Activities of Reprecipitated RNAP Fractions 
Fraction 
Ppt. pH 5.4 
Ppt. pH 5.4 insoluble in 0.5 M NaHCO~ 
Ppt. pH 5.4 soluble in 0.5 u  NaHCO, 
Ppt. pH 5.4 insoluble saline pH 7.2 
Ppt. pH 5.4 soluble in saline pH 7.2 
Mg. DNA 
0.013 
0.0 
0.0 
0.03 
0.0 
Mg. RNA 
1.023 
0.591 
1.182 
0.708 
1.276 
Mg. hexosamlne Per cent'of 
•  mice  dying 
Mg. N  out of 30* 
0.022  67 
0.032  60 
0.017  23 
0.024  77 
0.020  37 
* Total dose levels of 1.0, 0.3 and 0.05 administered to groups of 10 mice. 
not have been completely extracted under the relatively mild conditions used in 
the last two cases and the lipide fractions were not tested for activity. 
To determine whether or not the lipide fraction possessed enhancing activity, 
the following procedures were carried out:- 
One or two gin. samples of lyophilized whole tumor were extracted overnight with 50 ml. 
of organic solvents or a mixture of solvents at temperatures ranging from --20 to room tem- 
perature. In some eases, the mixture of organic solvent and lyophilized tumor was heated to 
50 or 60°C. in a water bath for 2 hours then allowed to stand at room temperature overnight. 
The portion of the tumor insoluble in the solvent was filtered out, washed with 100 ml. of the 
same solvent, and dried at room temperature. The extracts were evaporated in vacuo at room 
temperatures or lower and weighed. Lipide extracts were suspended in a saline solution con- 
taining 1 per cent tween 80 and injected into 10 mice. 
When  injected at  a  single dose level of 40 rag.  dry weight,  the extracted 
residues appeared to be fully active except when the solvent was 80 per cent 
alcohol or 3:1  alcohol:ether at 60°C.  (Table IV). However, when tested at 
lower dosage levels,  extraction with  alcohol:ether at  5°C.  caused a  marked 
decrease in activity while extraction in a  Soxhlet apparatus for 4 hours with A.  A,  KANDUTSCH AND U.  REINERT-WENCK  131 
alcohol and 4 hours with ether, appeared to destroy most of the activity. None 
of the mice receiving injections of the  lipides were killed by growth of the 
subsequently  inoculated  tumor;  however,  the  lipide  injections  sometimes 
caused the tumors to survive for a longer time and to grow on a much larger 
size before regressing. Attempts  to obtain the survival of tumor homografts 
TABLE IV 
Aai~ity of Lyophili~d Tumor after Extracgon with Organic Solvents 
Solvent 
None 
~0 per cent alcohol 
Acetone 
;: 1 alcohol:  ether 
None 
3:1 alcohol:  ether 
Temperature* 
Room temperature 
50°C. 
Room temperature 
5O°C. 
Room temperature 
50°C. 
Room temperature 
5O°C. 
6O°C. 
Overnight in refrigerator 
Overnight in  refrigerator  fol- 
lowed by Sox.hlet  extraction 
Exp. 1~; 
100 
9O 
5O 
70 
6O 
70 
Per cent dying 
Exp. 2 
100 
80 
00 
8O 
8O 
70 
40 
Exp. 31 
7O 
22.5 
7.5 
* In Experiments I  and 2 the  tumor was allowed to stand in  the solvent  overnight at  room 
temperature or was heated to 50 or 60  °  for 2 hours, then allowed to stand overnight at room 
temperature. 
A total  dose of  40 mg llpide-free  dry weight per mouse administered to I0 mice. 
§ Total dose levels  of 2.0,  1.0,  0.2,  and  0.05 rag.  N per mouse administered to groups of I0 
mice. 
until the death of the mouse, by increasing the total dose of lipide extract to 
300 rag. per mouse, by distributing the dose over 6 injections at 3 day intervals 
or by suspending  the lipides in a  2  per cent solution of lyophilized porcine 
serum (Mann Research Laboratories, Inc.) (22) were unsuccessful. 
pH Stability.--The accelerant factor studied by Shear et al. (5) was destroyed 
by 2 N NaOH while the active factor studied by Day et al. (15) was destroyed 
after exposure to pH 2 or lower or to alkaline solution at a pH of 11. Since, in 
neither of these studies was the stable pH range clearly defined, the following 
experiment was carried out.-- 132  SUBSTANCE  PROMOTING  TUMOR  HOMOGRA.FT  SURVIVAL 
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LSS was homogenized in saline at a concentration of 1.74 rag. ~/ml. The homogenate was 
divided into 10 ml. portions and the pH was slowly adjusted to the desired level with 0.1 
HC1 or 0.1 s  NaOH using a pH meter while the homogenate  was rapidly stirred with a 
magnetic stirrer. After standing for 1 hour at room temperature, the suspensions were carefully 
neutralized, diluted to the required concentrations,  and tested at the dose levels of 1.0 and 
0.33 rag. N/monse.  Since the pH was readjusted to neutrality after exposure of the LSS to 
alkaline or acid pH, only irreversible losses in activity were measured  in this experiment. 
While the procedure employed may have resulted in some loss of activity due 
to  high  local concentrations  of acid or alkali, it is apparent  that  the  active 
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FIo. 2. pH stability curve. The ordinate represents the per cent of mice dying out of 20 
when 2 groups of 10 mice received LSS at levels of 1.0 or 0.33 rag. s  per mouse. The pH was 
adjusted back to neutrality after 1 hour at room temperature. 
substance was  quite labile to dilute acid or alkali, activity being rapidly lost 
when the pH dropped below 5 or rose above 9  (Fig. 2) 
Effects of Certain Enzymes.--In early experiments it was found that treatment 
of a  suspension of LSS with trypsin caused it to become very viscous, probably 
owing to the release of DNA, so that particulate materials could no longer be 
sedimented by centrifugation. For this reason, in those experiments in which it 
was desirable to remove trypsin after the incubation period, the washed insol- 
uble residue (fraction 4) was used. This fraction did not contain a great deal of 
DNA and did not become viscous when treated with trypsin. 
Samples of insoluble residue weighing 400 rag. were homogenized with 15 ml. of 0.14 
saline. To the homogenates  were added 10 nil. of 0.1 K phosphate buffer (pH 7) containing 
50 mg. of crystalline trypsin, 50 mg. of crystalline hyaluronidase or buffer only. A sample of A.  A.  KANDUTSCH  AND  U.  REINERT-WENCK  133 
insoluble residue weighing 235 rag.  was homogenized with 20 ml. of unbuffered saline  con- 
taining 5 nag. of a  lyophili~d cell-free extract of V/br/o ¢ho/~rae containing  the receptor- 
destroying enzyme  (RDE)  1 (final pH 6.8). The mixtures were incubated  for 4 hours  with 
frequent  shaking in a 37  ° water bath. At the end of the incubation  period, an aliquot  con- 
raining 75 rag. dry weight of the insoluble residue fraction was removed from each mixture 
and centrifuged at 16000 g for 15 minutes. The supemate was carefully poured off and the 
residue was washed once with a small amount of saline, centrifuging as before. The first super- 
hate and the wash were combined and the supernates and the residues were lyophili~cl.  Hex- 
osamine was determined in both the residue and supematant fractions. Analysis of the crys- 
talline hyaluronidase showed the  presence of  considerable  hexosamine and the  values obtained 
for this supernatant  fraction  were corrected accordingly. No hexosamine was found in the 
trypsin and because of the small amount of R.DE available no analysis was made on this 
preparation. 
The remainders of the incubation mixtures, with the exception of the RDE mixture, were 
divided into two equal portions. One portion was centrifuged and washed as described above, 
discarding the wash supernate. The portion of the incubation mixture that was not centrifuged 
was diluted to the proper concentration with saline and injected at levels of 1.0, 0.2, and 0.05 
rag. s/mouse. The residue from the centrifuged portion was reconstituted  in saline to the 
initial  volume and diluted in the same way as the uncentrifuged portion.  The supemate of 
the centrifuged portion  was injected  in amounts equivalent  to 1.0 or 0.2 rag. N of the un- 
centrifuged suspension. The entire RDE incubation mixture not used for hexosamine analysis, 
was centrifuged and separated into residue and supernate as already described. 
Since the results obtained with enzymes were sometimes equivocal, parts of 
the experiment  described above were repeated  several  times and desoxyribo- 
nuclease  was also  tested  using  5  rag.  of desoxyribonuclease  and  0.025  molar 
MnCh  in  the  final  incubation mixture.  The  results  of these  experiments are 
added together and are included in Table V. 
Incubation with trypsin caused a  significant increase in the per cent of the 
total  hexosamine  found  in  the  supernate,  78.2  per  cent  of  the  total  being 
solubilized.  Incubation  with  hyaluronidase  did  not  increase  the  amount  of 
hexosamine  in  the  supemate  and  the  slight  increase  in  hexosamine  in  the 
supernate after incubation with the RDE preparation may have been at least 
partially due to hexosamine present in the RDE preparation. 
When  injected  with  the  tumor  fraction  both  trypsin  and  hyaluronidase 
caused a significant reduction in activity (groups 2, 3, 6, 7; Table V). However, 
when the enzyme was removed after the incubation period,  the material  that 
had been incubated with trypsin appeared to be as active as the uncentrifuged 
control even though most of the hexosamine had been removed. The material 
incubated with hyaluronidase also appeared to regain activity when the enzyme 
was removed. However, both the washed control and the washed hyaluronidase- 
treated  materials  appeared  to be less  active  than  the  uncentrifuged  control. 
Little significance was attached  to this apparently decreased activity since in 
other  experiments,  there  was  no  loss  in  control  preparations  under  similar 
1 We are indebted to Dr. Karl Meyer, College of Physicians and Surgeons, Columbia Uni- 
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conditions. Neither DNAase nor RDE had an appreciable effect on activity. The 
effects of incubation with lysozyme and ribonuclease were also tested in pre- 
liminary experiments. Neither of these enzymes appeared to alter activity. 
Effects of Urea and 90 per cent Phenol.-- 
LSS was homogenized with saline or 50 per cent urea previously adjusted to pH 9 with 
HC1. As the final pH of the urea homogenate was 9, an aliquot of the saline homogenate was 
adjusted to pH 9 with 0.1 N NaOH to control the effects of the alkaline pH. The suspensions 
were allowed to stand in the refrigerator for 7 hours. The neutral saline suspension and part 
of the urea homogenate were centrifuged for 30 minutes at 30,000 g. The supemates were 
TABLE  V 
Effects of Enzymatic  Digestions on the Activity of a Sarcoma I Fraction* 
Group  Enzyme 
None 
Hyaluronidase 
Trypsin 
RDE 
None 
Hyaluronidase 
Trypsin 
None 
DNAase 
Per cent of mice dying~ 
Total mixture§  Washed  residue§l  Supcrnate[] 
20  (30) 
26.7 (30) 
143  (30) 
'  43  (30) 
47  (30) 
13.3 (30) 
10  (30) 
45.6 (120) 
19.1 (120) 
J3,1 (120) 
45  (60) 
45  (60) 
lo (lO) 
o  (lO) 
o  (lO) 
o  (lO) 
i  r 
t 
Per cent  of total 
hexosamine 
in  supernate 
12.5 
13.5 
78.2 
20.4 
* Insoluble residue (fraction 4, Table II) used for groups 1 to 4, LSS for groups 5 to 9. 
~: Numbers in parenthesis are the total numbers of mice injected. 
§ Groups 1 to 4; total doses of 1.0, 0.3, and 0.05 rag. N per mouse administered to groups 
of 10 mice. Groups 5 to 9 total doses of 1.5, 0.5, and 0.05 nag. N per mouse administered to 
groups of 10 mice. 
11 Total dose equivalent to the volume of uncentrifuged mixture containing 1.0 nag. of N 
administered to 10 mice. 
separated and, along with the residues and the uncentrifuged urea and saline homogenates, 
were dialyzed overnight in running water at 5°C. The dialyzed preparations were freeze-dried 
and tested for enhancing activity. 
Sarcoma I was also fractionated by extraction with 90 per cent phenol with no prior treat- 
ment of the tumor tissue essentially as described by Howe and Kabat (23), except that the 
phenol-soluble fraction was precipitated by the addition of 2 volumes of alcohol. 
As shown in Table VI, treatment with urea or phenol resulted in complete 
loss of activity. 
Effects of Oxidizing Agents.- 
Samples of LSS weighing 364 or 728 rag. were homogenized in 20 ml. of phosphate buffered 
saline (pH 7) or in buffered saline containing NaIO~, KMnO4, K~Cr~t or H~O~ at a  concen- 
tration of 0.01, 0.001, or 0.0001  molar. After standing for a period of time, the suspension was A.  A.  KANDUTSCH  AND  U.  REINERT-WENCK  135 
TABLE  VI 
E~eas of Urea and Phenol on the Acff~i@ of a Sa I  LSS Fraction 
Treatment  Mg. N/mouse*  Per cent of mice dylngt 
Saline 
Soluble in 50 per cent urea 
Insoluble in 50 per cent urea 
50 per cent urea (not fractionated) 
Saline, pH 9 
Soluble 90 per cent phenol 
Insoluble 90 per cent phenol 
I,  0.2,  0.05 
I,  0.2 
I,  0.2,  0.05 
1.0 
1.0 
3.0 
3.0 
6o (3o) 
o  (2o) 
o  (3o) 
o  (to) 
5o (lO) 
o (2o) 
o (2o) 
* Each dose was administered to 10 mice. 
~: Numbers in parenthesis are the total numbers of mice injected. 
TABLE VII 
The E~eas of Oxidizing  Agents on the Enhancin  Activity of a 
Molarit  7  of 
Oxidizing agent  oxidizing  Time exposed  Washed* 
agent 
~one§ 
NalO, 
~c 
NaI04 inactivated 
with glucose 
N 
0.01  1 hr. 
0.01  20 rain. 
0.001  1 hr. 
0.0001  1  " 
0.01  1 hr. 
s~IO, lt 
Sonell 
KMnO, 
ac 
H~2 
fc 
K2Cr207 
0.01  1 hr. 
0.01  1 hr. 
0.001  1  " 
0.01  1 hr. 
0.001  1  " 
0.01  1 hr. 
0.001  1  " 
Yes 
Yes 
~L 
C~ 
Yes 
No 
No 
Yes 
Yes 
Yes 
cc 
Mrcoma I  LSS Fraaion 
No. of mice dying out of 10 
1.5 Mg. N~  3.0 n~. N$ 
9  8 
0  1 
0  0 
3  8 
I0  I0 
10  10 
0 
I0 
2 
6 
10 
I0 
8 
9 
* Centrifuged for 15 minutes of the indicated time at 3°C., sediment washed with glucose 
solution. 
Dose per mouse. 
§ At dose levels of 0.5 and 0.05 rag. N per mouse, numbers of mice dying were 9 and 0 out 
of 10 respectively. 
II At the end of the indicated period of time glucose was added to inactive excessive perio- 
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centrifuged at 4500 g for 20 minutes, the supexmate  was discarded and the residue was washed 
once with 10 ml. of 2.5 per cent glucose, and centrifuged again. The glucose  wash was poured 
off and the sediment homogenized in saline. Dosage was calculated with the assumption that 
essentially all of the LSS was recovered in the sediment at the centrifugal speed used. In 
some cases, the mixtures were not centrifuged but glucose was added to inactivate excess 
periodate ion. To determine the effects of the products resulting from the action of periodate 
ion on carbohydrates present in the LSS, 200 mg. of glucose were added to 20 ml. of 0.01 M 
NaIO4 in buffered saline and allowed to stand  1 hour at room temperature after which the 
mixture was used to treat a sample of the LSS as described above. 
The results shown in Table VII demonstrate that the activity of the LSS was 
rapidly lost after exposure to dilute sodium periodate. The loss occurred in the 
uncentrifuged mixture as well as in the cases in which  the periodate ion was 
washed away indicating that the active substance was not converted to a soluble 
form and removed. Treatment with KMnO, also, caused a reduction in activity 
although  KMnO4  was  less  effective than  NaIO4 under  the  same conditions. 
Hydrogen  peroxide,  potassium  dichromate,  and  sodium  periodate  that  had 
reacted with glucose had no effect on activity. 
DISCUSSION 
The donor and host mice used in the tests for the enhancing substance in 
the present experiments are genetically quite different. Thus the possibility that 
several chemically distinct substances may act together or separately to produce 
the enhancing effect must be considered. The failure to identify activity with 
any one cellular fraction may indicate that this is true. However genetic factors 
concerned with homograft acceptance or rejection are relatively few in number 
(24), and by analogy with other isoantigen systems (i.e.  the blood groups) the 
several substances involved may all fall into the same chemical class. According 
to the latter view, the presence of activity in different cellular fractions would be 
due to the presence of a  common particle. In this connection it is noted that 
membranous structures of the cell have been demonstrated in mitochondrial, 
microsomal, and nuclear preparations (25-27). 
A  significant finding  in  the present  experiments was  the presence of high 
concentrations of the activity in the insoluble residue fraction. In this fraction, 
the active substance appeared to be almost completely insoluble in water or 
salt solutions. Although the composition of the insoluble residue fraction, out- 
side of the presence of large amounts of connective tissues, was unknown, it is 
unlikely that much cytoplasmic material was present. 
Important clues  to  the  chemical nature  of the  active substance(s)  are its 
lability to periodate ion and to protein-denaturing  agents. Although not con- 
clusive, the evidence available suggests that the periodate may be acting on a 
carbohydrate component in its relatively specific capacity to split carbon-carbon 
bonds where  there are adjacent  hydroxyl or hydroxyl and amine groups.  In 
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activity in comparison to that of other strong oxidizing agents,  the lack of an 
appreciable effect of NaIO4 on the enhancing activity of a globulin fraction ob- 
tained from mouse antisera  (9), the relatively prolonged exposure to periodate 
ion needed to obtain extensive inactivation  of certain biologically active pro- 
teins (28-30) and the similar inactivating effect of periodate ion on mucoprotein 
or mucopolysaccharide antigens (31, 32). An alternative, but in the view of the 
authors, less likely explanation of the effect of periodate is that the activity of 
the active substance  is dependent  on the hydroxylysine residues or terminal 
hydroxyam~no acids of a protein. 
That a protein does constitute a part of the active substance is evident from 
the  inactivating  effect of  protein-denaturing  agents.  Indeed,  the  enhancing 
factor appeared  to be more labile to protein-denaturing  agents  than  are  the 
antigenic properties of at least some proteins, which may retain their specifici- 
ties even after extensive denaturation  (33, see reference 34 for extensive bibliog- 
raphy). If on the basis of the inactivating effect of NaIO4 the active substance 
is postulated  to contain a  carbohydrate moiety, the lability of the enhancing 
substance  to protein-denaturing  agents  can  be  accounted  for  in  two  ways: 
(a) denaturation  of a  specific protein which is conjugated to a  specific carbo- 
hydrate or (b) the dissociation of a protein which may or may not be specific 
from a specific carbohydrate. The latter process might eliminate the capacity of 
the enhancing factor to evoke antibody without altering the antigenic specifici- 
ties of either the protein or carbohydrate. Whether one of these ways is correct 
cannot  be decided  on  the  basis of the  present  experiments;  but,  it  may be 
pointed out that, when their structure is known, all isoantigens studied thus far 
consist  of  a  specific  non-protein  heptene  conjugated  with  a  relatively non- 
specific protein. 
More complete characterization  of the enhancing factor is largely dependent 
on obtaining  the substance in a  relatively pure state.  Obvious difficulties are 
involved in isolating a substance that is apparently insoluble and at the same 
time labile to such agents as acid, alkali, urea, and phenol. The development of 
a  serological  test might  overcome most of these difficulties,  since serological 
activity might be more stable than  the capacity to evoke antibody. It is also 
possible that, like some mucopolysaccharide haptens (35) a mucopolysaccharide 
fraction  from  the  tumor  can  be  reactivated  by combination  with  a  foreign 
protein. 
SUMMARY 
Using the death of mice due to the growth of tumor homografts as an end 
point, the distribution  and properties of a tumor homograft-promoting  sub- 
stance(s),  the "enhancing substance," were studied. 
Activity was most largely  present in tumor and spleen tissues  while that in 
the liver,  kidney, and stomach was relatively  slight. 138  SUBSTANCE  PROMOTING  TUMOR  HOMOGRAFT  SURVIVAL 
Activity was widely distributed in fractions prepared from tumor. Although 
DNAP and crude RNAP fractions were active, activity could not be associated 
with either RNA or DNA. The fraction possessing the highest concentration of 
activity was a residue fraction which was insoluble in water or in dilute or strong 
saline solutions. 
Extraction of lyophilized tumor with acetone or 3:1  alcohol:ether reduced, 
but did not eliminate, activity in the insoluble fraction. However, activity was 
completely lost after extraction with 80 per cent alcohol at room temperature. 
Enhancing activity of a  tumor fraction was irreversibly lost after exposure 
for 1 hour to a solution more acid than pH 5 or more alkaline than pH 9. Activ- 
ity was completely lost after exposure to 50 per cent urea or 90 per cent phenol. 
Activity was not altered by incubation with trypsin, hyaluronidase, DNAase 
or the receptor-destroying enzyme of V. cholerae, but it was decreased when 
trypsin or hyaluronidase was injected with the incubated tumor fraction. 
Activity was rapidly destroyed by treatment with dilute solutions of sodium 
periodate at pH 7. Under similar conditions, treatment with KMnO4 resulted in 
less extensive destruction of activity while H,O2,  K2Cr2OT, and  NaIO,  pre- 
viously inactivated by reaction with glucose had no apparent effect on activity. 
These results are interpreted as indicating the presence of both carbohydrate 
and protein in the structure of the activity substance. 
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